1 of 1
Story summary
- Cade Jobsis, the 4-year-old son of the Jobsis family, will begin treatment in Texas in early December after raising $1.15 million for his clinical trial.
- Emma Jobsis stresses the need for accessible clinical trials for rare diseases, citing gaps in research and funding.
- The family previously raised $3 million with other families for the drug's cost and discovered an additional $1.15 million was needed for hospital treatment.
